STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
Conversions, 180 days
10
Codes C/M, not in net · $3.8M priced
What the filings say about ACU
Insiders, 180 days
-$1.7M net sold
4 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$1.3M
3 notices
Acme United insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, ACME UNITED CORP insiders sold a net $1.7M of stock across 78 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
Nobody has filed for crossing 5%. That is a fact, not missing data.
ACU planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
OLSCHAN BRIAN S
Filed 2026-08-17
$453.1K
Rex Davidson
Filed 2026-08-10
$207.9K
OLSCHAN BRIAN S
Filed 2026-08-03
$620.3K
Executive pay vs shareholder return
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$1.7M
$1.5M
$1.2M
+94%
n/a
2024
$1.2M
$1.1M
$831.7K
+77%
n/a
2023
$1.8M
$2.5M
$1.2M
+100%
n/a
2022
$1.3M
$997.0K
$863.0K
-33%
n/a
2021
$1.8M
$1.6M
$1.1M
+11%
n/a
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $1.7M sold by insiders over 180 days, $1.3M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
TTM operating cash flow over long-term debt only, 2026-06-30
Cash flow to debt ACU
FY Dec 2025
1.54x
FY Dec 2024
0.68x
FY Dec 2023
2.21x
FY Dec 2022
0.06x
FY Dec 2021
0.16x
Jun 2026
1.15x
Mar 2026
0.59x
Dec 2025
1.54x
Sep 2025
0.90x
Jun 2025
1.12x
Mar 2025
0.92x
Dec 2024
0.68x
Sep 2024
0.58x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+8.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity ACU
FY Dec 2025
+9.1%
FY Dec 2024
+9.8%
FY Dec 2023
+20.1%
FY Dec 2022
+3.9%
FY Dec 2021
+19.5%
Jun 2026
+8.4%
Mar 2026
+8.5%
Dec 2025
+9.1%
Sep 2025
+9.0%
Jun 2025
+9.5%
Mar 2025
+9.7%
Dec 2024
+9.8%
Sep 2024
+20.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+5.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets ACU
FY Dec 2025
+6.1%
FY Dec 2024
+6.4%
FY Dec 2023
+11.3%
FY Dec 2022
+2.0%
FY Dec 2021
+10.0%
Jun 2026
+5.3%
Mar 2026
+5.3%
Dec 2025
+6.1%
Sep 2025
+5.9%
Jun 2025
+6.0%
Mar 2025
+6.2%
Dec 2024
+6.4%
Sep 2024
+12.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+8.4%
operating income after a 21.2% effective tax rate, over long-term debt only, 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital ACU
FY Dec 2025
+9.6%
FY Dec 2024
+10.1%
FY Dec 2023
+10.7%
FY Dec 2022
+4.2%
FY Dec 2021
+11.7%
Jun 2026
+8.4%
Mar 2026
+7.7%
Dec 2025
+9.6%
Sep 2025
+9.1%
Jun 2025
+9.6%
Mar 2025
+9.5%
Dec 2024
+10.1%
Sep 2024
+9.8%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+9.2%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed ACU
FY Dec 2025
+10.2%
FY Dec 2024
+10.8%
FY Dec 2023
+9.9%
FY Dec 2022
+4.7%
FY Dec 2021
+10.9%
Jun 2026
+9.2%
Mar 2026
+8.9%
Dec 2025
+10.2%
Sep 2025
+9.6%
Jun 2025
+9.6%
Mar 2025
+10.0%
Dec 2024
+10.8%
Sep 2024
+10.2%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
26.71x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing ACU
FY Dec 2025
16.19x
FY Dec 2024
15.30x
FY Dec 2023
8.84x
FY Dec 2022
27.04x
FY Dec 2021
9.80x
Jun 2026
20.05x
Mar 2026
19.36x
Dec 2025
16.19x
Sep 2025
16.81x
Jun 2025
16.38x
Mar 2025
16.10x
Dec 2024
15.30x
Sep 2024
8.25x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$261.4M
market value at close 2026-10-26 on 2026-08-01 shares, plus long-term debt only, 2026-06-30, minus cash 2026-06-30
Enterprise value ACU
FY Dec 2025
$161.7M
FY Dec 2024
$150.9M
FY Dec 2023
$162.0M
FY Dec 2022
$121.2M
FY Dec 2021
$148.2M
Jun 2026
$199.4M
Mar 2026
$199.9M
Dec 2025
$161.7M
Sep 2025
$169.6M
Jun 2025
$169.8M
Mar 2025
$165.7M
Dec 2024
$150.9M
Sep 2024
$170.2M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+6.4%
TTM free cash flow over market value at close 2026-10-26
FCF yield ACU
FY Dec 2025
+4.9%
FY Dec 2024
+3.5%
FY Dec 2023
+15.8%
FY Dec 2022
-1.8%
FY Dec 2021
-1.0%
Jun 2026
+8.5%
Mar 2026
+4.8%
Dec 2025
+4.9%
Sep 2025
+3.2%
Jun 2025
+7.8%
Mar 2025
+8.0%
Dec 2024
+3.5%
Sep 2024
+4.0%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -6%, PEG needs growth
PEG, trailing ACU
FY Dec 2025
7.90x
FY Dec 2024
n/a
FY Dec 2023
0.02x
FY Dec 2022
n/a
FY Dec 2021
0.20x
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
7.90x
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
0.04x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
ACU ranks highest on financial health (81st percentile) and risk and compliance (52nd), and lowest on institutional and government (1st), among Industrials peers.
Profitability
50
Inputs
Return on equity+8.4% · 48 pct, sector of 198
Return on assets+5.3% · 60 pct, sector of 224
Return on invested capital+8.4% · 32 pct, sector of 107
Return on capital employed+9.2% · 59 pct, sector of 195
Financial health
81
Inputs
Debt to equity0.19x · 70 pct, sector of 214
Cash flow to debt1.15x · 92 pct, sector of 173
Growth
34
Inputs
Revenue growth, YoY+1.1% · 34 pct, sector of 254
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
22
Inputs
Net Form 4 buying (codes P and S), 180d-$1.7M · 45 pct, sector of 170
Insider buyers, 180d0 · 0 pct, sector of 172
Institutional and government
0
Inputs
Funds adding, latest quarterfewer than five funds report holding it
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quarters$30K · 0 pct, sector of 67
Risk and compliance
52
Inputs
Short interest, % of float+2.5% · 70 pct, sector of 269
Recalls per $1B revenue, 3y111.94 per $1B · 0 pct, universe of 292
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 191
New text in Risk Factors, latest 10-K+14.3% · 37 pct, sector of 197
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
ACU filings, in plain words
Are Acme United insiders buying or selling ACU?
In the 180 days to 2026-10-27, Acme United insiders were net sellers, a net $1.7M across purchases and sales reported on Form 4, by 4 sellers.
Are there planned insider sales of ACU?
Yes. 3 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $1.3M of stock; the latest, by OLSCHAN BRIAN S, was filed 2026-08-17.
Read the full summary
In the 180 days to 2026-10-27, Acme United insiders were net sellers of ACU, a net $1.7M across purchases and sales reported on Form 4 by 4 sellers. None of the 13 insider sales was flagged as made under a Rule 10b5-1 plan. Insiders filed 3 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $1.3M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.